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Introduction
Mitochondria are eukaryotic organelles in the cytosol of eukaryotic cells whose main function is to generate energy in the form of ATP, and regulate key cellular functions including the redox state of cells, apoptosis, calcium homeostasis, cellular differentiation and growth (1, 2). The numbers of mitochondria can vary from hundreds to thousands per cell, depending on the cell"s bio-energetic requirements (3, 4) .
Mitochondria contain their own circular DNA genome, and as each mitochondrion can contain 2-10 copies of 5-μm circular mitochondrial DNA genome, cells with mitochondria contain hundreds to thousands of copies of MtDNA per nuclear genome (5) . MtDNA is transcribed and translated within the mitochondrion and its replication is independent of phase-restricted nuclear DNA and the cell cycle and responds to physiological stimuli (6) . It is generally assumed that MtDNA level correlate with both mitochondrial function, and the number of mitochondria in the cell (3, 4) . However, altered MtDNA levels associated with disease in blood samples, body fluids, and cells and tissues have been reported in a wide range of human disease leading to the hypothesis that changes in MtDNA content may be indicative of mitochondrial dysfunction (7) . Alterations in MtDNA may be indicative of altered metabolic activity; or they can also be indicative of potential inflammatory pathways, as MtDNA has emerged as a mediator of inflammation as if in the wrong place, it can activate immune responses because of the resemblance to bacterial DNA (8, 9) .
The mitochondrial genome comprises of 16,569 base pairs (bp) in humans and between 16, 769 bp in mouse (10) . MtDNA is highly conserved between organisms and encodes 37 genes; 13 mRNAs, 2 rRNAs and 22 tRNAs and 1 non-coding D-loop region (6) .
The remainder of >1500 mitochondrial proteins are encoded by nuclear genome, transcribed into mRNAs, translated on cytoplasmic ribosomes, and imported into the mitochondrion (11) .
Fragments of mitochondrial genome are present in the nuclear genome in the form of
pseudogenes called NumtS (Nuclear mitochondrial insertion sequences), which have been found to lead to erroneous identification of mitochondrial heteroplasmies (12, 13) .
The quality and quantity of MtDNA is widely employed as a determinant of mitochondrial activity. The most commonly used method used measure MtDNA content in a cell is to quantify the mitochondrial genome versus nuclear genome ratio, termed Mt/N (7, (14) (15) (16) . The problem with MtDNA quantification methods is that co-amplification of NumtS is likely to lead to erroneous data when measuring MtDNA content or the presence of MtDNA mutations. Furthermore, southern blot based methods are still in use (17) which are likely to lead to cross hybridisation of NumtS rather than specifically MtDNA. To overcome this issue, we previously developed a PCR-based method by identifying unique regions in the human mitochondrial genome not duplicated in the nuclear genome to accurately quantify
MtDNA from human samples (16) . However, a similar approach has not been described for mouse MtDNA and there is little information in the literature about whether mouse MtDNA is present as NumtS in the nuclear genome. Therefore in the current paper our objective was to investigate the presence of NumtS in the mouse nuclear genome, define regions in the mouse mitochondrial genome which are unique and not duplicated in the nuclear genome, and to use primers designed to these in order to accurately measure MtDNA copy numbers in a range of mouse tissues.
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2.1.Identification of unique regions of mitochondrial genome and primer design
The duplication of the mitochondrial genome in the nuclear genome was detected using BLAST version 2.2.32 (http://www.ncbi.nlm.nih.gov) (18) . Unique regions were identified in the mouse mitochondrial sequence, retrieved from ENSEMBL (19) using FASTA version 3.5.2.7 (20) as described previously (16) . To measure nuclear DNA, primers against single copy nuclear gene, Beta-2 microglobulin (B2M) were designed (Table 1 ).
2.2.Animals
Male C57BL/6 mice (Charles River, Margate, UK) were kept in standard conditions. All animal procedures were approved by our institution"s Ethics Committee and carried out under license, in accordance with the UK Home Office Animals (Scientific Procedures) Act 1986.
Animals were sacrificed when they reached 3 months of age according to approved protocols and tissue and blood samples of these mice were collected and immediately snap frozen.
Samples were stored at -80⁰C.
Genomic DNA preparation
Tissue samples were homogenized using TissueLyser (Qiagen) in order to eliminate crosscontamination. Total genomic DNA was extracted using the DNeasy Blood & Tissue kit according to manufacturer"s instruction (Qiagen) (16) . Before proceeding to qPCR, the DNA template was subjected to the pre-treatment (DNA template shearing using bath sonicator Kerry, Pulsatron 55 which uses 38kHz+/-for 10 minutes) as described previously (15, 16) in order to avoid dilution bias. The template concentration was determined using NanoDrop and adjusted to 10ng/μl. To avoid errors arising from repeated freeze thaw cycles DNA samples were kept at 4 o C for the duration of study.
Real-time PCR
MtDNA content was assessed by absolute quantification using real time PCR. Primers for mouse MtDNA (mMitoF1, mMitoR1) and mouse B2M (mB2MF1, mB2MR1) were used to amplify the respective products from mouse genomic DNA (Table1). PCR products were purified and used to prepare dilution standards for both amplicons and the range of dilutions used were 10 2 -10 8 copies per 2μl to allow absolute quantification. MtDNA copy number per cell were determined from template DNA by carrying out qPCR in a total volume of 10μl, containing 5μl of Quantifast SYBR Master Mix (Qiagen), 0.5μl of forward and reverse primer (400nM final concentration each), 2μl template DNA and 2μl of DNase free water.
The reactions were performed in Roche LightCycler (LC) 480 instrument using the following protocol: pre-incubation at 95°C for 5 min (1 cycle); denaturation at 95°C for 10 s, annealing and extension at 60°C for 30 s (repeat denaturation and extension steps for 40 cycles), melting at 95°C for 5 s, 65°C for 60 s, and 95°C continues (melt curve analysis -1 cycle) and the last step, cooling at 40°C for 30s. The specificity of the primers (one PCR product amplified) was confirmed as a single melt peak and single band when electrophoresed on 2% agarose gel for both amplicons (not shown). qPCR efficiency calculated from the slope was between 95-105% with co-efficiency of reaction R 2 =0.98-0.99.
Results

Identification of nuclear mitochondrial insertion sequences (NumtS) in the mouse genome
We used the mouse mitochondrial genome sequence (accession number NC_005089.1) derived from Mus musculus (21) and which shows high sequence identity with mitochondrial genomes from commonly used mouse strains, to search for similar sequences in the mouse nuclear genome reference sequence using blast (NCBI, http://blast.ncbi.nlm.nih.gov/Blast.cgi
Mus Musculus). The resulting data showed that many regions of the mouse mitochondrial genome showed strong sequence identity (>90%) with regions located in the nuclear genome, suggesting that these regions contain NumtS (Figure 1a ). NumtS were found in 15 out of 21 mouse chromosomes and ranged from 30bp to 4654bp ( Figure 1b ). More than 95% of the mouse mitochondrial genome was present in varying lengths and different positions in the mouse nuclear genome.
Design of unique primers to amplify mouse mitochondrial DNA
The mouse mitochondrial genome sequence was split into overlapping fragments of 150bp length with a 50bp overlap at each end, and each fragment was used as a query sequence in a FASTA search against the entire mouse genome, one chromosome at a time (both strands).
Each candidate "unique" sequence was tested using BLAST to ensure programmatic accuracy. Using this approach, a unique mitochondrial sequence of 211bp was identified, this region flanks position 1323-1447 of the mouse mitochondrial genome (accession number NC_005089.1), and accounts for less than 1.5% of the whole mouse mitochondrial genome.
In addition, we found that between positions 200-3000 of the mouse mitochondrial genome, the frequency and length of NumtS were smaller and presence of other unique regions might be possible. We used the sequence at position 1323-1447 to design primers mMitoF1 and mMitoR1 which do not co-amplify NumtS (Table 1) .
Absolute quantification of mouse mitochondrial DNA
The primers designed above were used to test the accuracy and reproducibility of the assay using mouse kidneys (Figure 2 ). Total DNA isolated from kidneys of C57BL/6 mice (n=18) was used as template for amplification and quantification of the two target regions using mmito and mB2M primers ( Table 1 ). The template DNA was sonicated, the concentration adjusted to 10ng/ul, and qPCR was carried out in triplicate for 10 ng and 1 ng per template, the resulting averages representing 6 measurements per original sample for each gene were used to calculate the mitochondrial genome to nuclear genome ratio in the samples ( Table 2) and to test the accuracy of the assay (Figure 2a ) We next used the assay to determine the accurate amount of MtDNA in a range of mouse tissues and blood samples (Figure 3 ) as the mitochondrial genome to nuclear genome ratio.
MtDNA was detected in all samples. The highest detected MtDNA copy number was in the heart (1273 copies/nuclear genome) followed by the kidney (332 copies/nuclear genome) and surprisingly, the lowest was in lung and islets (6 and 33 copies/ nuclear genome respectively, Figure 3 ).
Discussion
In this study, we have described the measurement of mouse MtDNA content using real-time qPCR and primers targeting a unique sequence in the mouse mitochondrial genome without potential errors could skew data, especially when one considers that the extraction method (29) , storage and pre-treatment of the template (16) can cause an unequal distribution of the nuclear DNA and MtDNA in samples (7) . Many NumtS are presented several times in the nuclear genome and it has been suggested that their copy numbers can change with disease.
For example, Caro et al., (2010) showed that mitochondrial sequences corresponding to cytochrome oxidase III and 16srRNA were present in purified nuclei of liver and brain tissues from young and old rats. Interestingly, these regions contained the same SNPS found in the mitochondrial genome of the same age and their copy numbers increased with age. This study suggests that NUMTs are variable with age and is an additional reason to avoid using PCR procedures which amplify NUMTs (30) . We suggest that attempts should be made to minimise experimental errors by ensuring that the target sequences are specific and that the protocols employed do not affect data due to co-amplification of NumtS, dilution bias or storage issues as described earlier (16, 29) . Our mtDNA quantification approach has undergone rigorous quality control; The assay is carried out at optimized template concentrations after template pre-treatment to enhance accuracy, ensuring that the "dilution effect" caused by the differing solubility of the mitochondrial genome versus the nuclear genome is minimized. The issues around template preparation and handling stem from the differing genome sizes, the mitochondrial genome is small and circular, the nuclear genome is large and comprised of linear fragments, and the two genomes have differing properties in solution resulting in skewing of the ratio. Therefore in the assay each target was measured using absolute quantification in triplicate at 2 different dilutions. The assay shows >99% primer specificity, quantity CV of <5%, <5% plate to plate variability and has been validated by comparison of output from >4 independent lab workers.
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The unique primers which we describe here do not co-amplify mouse NumtS and therefore can be used to determine absolute copy numbers of MtDNA in a range of mouse tissues as well as in conditions of disease. We found that the tissues with the highest MtDNA content were heart and kidney, and surprisingly, the lowest MtDNA content was found in lung, being even lower than whole peripheral blood. These findings correlate with results reported by others in human (36) and in rat tissues (37) . It would be interesting to determine if MtDNA content in different organs and cell types is indicative of bioenergetic function, and whether tissues such as heart and kidney, which contain the highest levels of MtDNA, are more prone to MtDNA damage and MtDNA mediated inflammation. Highlights  DNA fragments identical to the >95% of the mouse mitochondrial genome are present as nuclear mitochondrial insertion sequences (NumtS) in the nuclear genome  Unique regions in the mouse mitochondrial genome which do not co-amplify NumtS were identified  Primers described in this paper will allow the use of real time qPCR for determination of MtDNA content in different mouse tissues in differentiation and disease without coamplification of numtS  MtDNA content was measured in a range of tissues and was the highest in the heart and the kidney
